When the Stockholm and 468C strains of type C and the 1873 strain of type D Clostridium botulinum are "cured" of their prophages, they simultaneously discontinue the production of their dominant toxins (Cl and D), but they continue to produce a second antigenically monospecific toxin (C2). These "cured" strains of types C and D therefore become indistinguishable with respect to the toxin produced. Fifteen type C cultures received from other laboratories discontinued to produce the dominant toxin when subcultured in broth. The C2 toxin, however, was produced by eight of these cultures. The C2 toxin is produced by these cultures as a protoxin that requires treatment with trypsin before its toxicity can be demonstrated. Of the 21 type C cultures that produce the C1 toxin, 20 were shown to produce the C2 toxin. The filtrates of 14 of these cultures required trypsin treatment before the C2 toxicity could be demonstrated. Low levels of toxicity could be demonstrated in the six remaining culture fluids without trypsin; toxicity, however, was increased with trypsin.
It was previously reported (5, 6, 14, 15) that changes from nontoxigenicity to toxigenicity in Clostridium botulinum type C (strains 468C and Stockholm) and type D (strains 1873 and South African) required the active and continued participation of specific bacteriophages. Subsequent studies on the relation of bacteriophages to the toxigenicity of types C and D have confirmed earlier reports that "curing" these strains of their prophages does result in a concomitant loss of the dominant toxic components. In these same studies, however, we have found that the "cured" isolates of the Stockholm, 468C, and 1873 strains continue to produce low levels of a second toxin that is antigenically monospecific. This toxin is produced by these cultures as a protoxin, and the culture filtrates are toxic only after trypsin treatment.
This report describes the production and some of the characteristics of the trypsin-activated toxic components (designated as C2) that are produced by different strains of types C and D. The toxic components produced by the types C and D cultures used in our experiments are designated as Cl, C2, and D on the basis that they are neutralized by the corresponding homologous antiserum prepared by Jansen (16) .
The activation of the toxin of types C and D
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by trypsin has not been previously reported. By using the trypsin treatment, we have demonstrated that some types C and D cultures previously thought to be nontoxic do produce the C2 toxin. (5, 6) . Strains A028, A050, A022, UV84, AOA113, A020, A078, and A012 were isolated from the above toxigenic strains, respectively; they discontinue the production of the dominant toxic components. Strain X220B2NT discontinued production of C, toxin after daily transfers of strain X220B2 in TYG medium.
Toxin and antitoxin production. Toxin assays and neutralization. Toxin titrations were made by diluting samples in half-log intervals in gelatin-phosphate diluent, and injecting 0.5 ml of each dilution intraperitoneally into each of five white mice. The LD50 dose was calculated by the method of Tint and Gillen (23) .
The effect of pH and incubation time on increasing the toxicity of the C2 component by trypsin was studied at 37 C by procedures of Duff et al. (4) . The C2 toxin was produced by culture A028 in cellophane tubes at 33 C. The culture supernatant fluid was filter-sterilized and the filtrate was adjusted to the specified pH. Trypsin (Difco, 1:250) was added to a final concentration of 0.25%. For routine analysis, the sample supernatant fluids were treated with 0.25% trypsin at pH 6.5. The effect of crystalline trypsin on the toxicity of C2 was also studied at pH 6.5 with a final trypsin concentration of 0.01%.
Toxin neutralization tests were made by injecting pairs of mice with 0.5 ml of a mixture composed of 0.4 ml of toxic fluid or dilutions thereof and 0.1 ml of monovalent antitoxin.
The RESULTS Antisera prepared at our laboratory and by B. C. Jansen (Republic of South Africa) against the different toxins of types C and D were exchanged for comparison. The toxins discussed in this report therefore correspond to the C1, C2, and D toxins reported by Jansen (16) .
Production of trypsin-activated toxin C, by strain A028. The highest concentration of the C2 toxin (350 LD50/ml) was produced by strain A028 in culture tubes when the glucose concentration of TYG medium was 0.2%. This toxin was present in the culture supernatant fluid as a protoxin and was toxic only after treatment with trypsin. When the glucose concentration was increased to 1%, production of the C2 toxin was markedly inhibited. When strain A028 was grown in cellophane tubes, toxicity of the clarified supernatant fluid was 356 LD50/ml before treatment with trypsin, and this was increased to 2,000 LD50/ml by treatment with trypsin. The optimal glucose concentration of TYG for C2 toxin production in cellophane tubes was 0.5%. Although the C2 toxin was precipitated over a wide range of (NH4)2SO4 concentration, the precipitate that formed at 40% saturation contained most of the C2 toxin (20,000 LD50/ml after trypsin treatment). The C1 titer of this fraction was 1.1 x 106 LD50/ ml but the C2 titer was only 4 LD 0/ml. The Cl toxic solution to be toxoided was diluted in 0.1 M phosphate buffer until the C2 toxin was no longer detectable.
Effect of pH and incubation time on increasing toxicity of C2 toxin by trypsin. Clarified supernatant fluids of culture A028 grown in cellophane tubes were used. The effects of the conditions of trypsinization on the toxicity of C2 toxin are summarized in Table 1 . The largest increases in toxicity occurred at pH 6.5 after 1 hr. No increases in toxicity were observed at pH 5.0 even after 24 hr of exposure to trypsin. The toxicity decreased markedly in the pH range of 6.0 to 7.5 when exposed to trypsin for 24 hr. The results are comparable to those reported for type E toxin by Duff et al. (4) with the exception that the optimal pH for activating type E toxin is 6.0 as compared to pH 6.5 for C2 toxin. On the basis of these observations, routine trypsinizations were done with final concentration of 0.25% trypsin, pH 6.5, and incubation for 60 min at 37 C.
The effect of crystalline trypsin at a final concentration of 0.01% on C2 toxicity was studied at pH 6.5. The increases in toxicity were comparable to that obtained with the Difco 1: 250 trypsin.
Cross-neutralization tests. The results of the cross-neutralization tests are summarized in Table 2 . Antitoxin prepared against the C, toxin neutralized C0 toxin but not the C2 toxin. Likewise, the antitoxin prepared against the C2 toxin neutralized the C2 toxin produced by both types C and D cultures but did not neutralize the Cl or D toxins. Type C antisera received from CDC, M. Cardella, and L. Ds. Smith neutralized the Cl toxin but not the C2 toxin. In contrast, the type C antisera produced against culture X220B2 (received from W. Jensen) neutralized both the Cl and C2 toxins. The X220B2 antiserum was produced in horses by using toxoid prepared from toxic filtrates of X220B2 grown in cellophane tubes (W. Jensen, personal communication). The cellophane tube procedure probably accounts for the presence of the C2 antitoxin in this antiserum.
When type C cultures produced both C l and C2 toxins, the mice were protected from the Cl toxin by type C antiserum received from L. Ds. Smith and M. Cardella. These type C antisera contain both the Cl and D but not the C2 factors (Table 2 ). This enabled the C2 toxin, which is usually masked by the dominance of the C, toxin, to express itself. The C2 toxin in all cases was neutralized only by the C2 antiserum. For simplicity, the cultures will be referred to as "toxic" if they produce dominant component C, and "nontoxic" if they do not produce the C, component. "Nontoxic" cultures A028, A050, A022, and UV84 were isolated in this laboratory; the remainder were received from other laboratories and which were nontoxic after the first transfer in SFEM or TYG media. Of the 21 "toxic" cultures tested, 20 produced toxin which was neutralized only by the C, antitoxin ( Table 3 ). The C2 toxin was detected in 14 of these cultures only after their supernatant fluids were treated with trypsin. The C2 toxin produced by six of the cultures was detectable (4 to 8 LD,,/ml) when the undiluted and untrypsinized supernatant fluid was used. The titers of these cultures were increased to 200 to 300 LD,0/ml by trypsin treatment. Strain FH6513 did not produce lethal levels of the C2 toxin even when it was cultured in cellophane tubes. It is possible, however, that the C2 toxin may be produced in different media.
Of the 19 "nontoxic" strains cultured in screw-capped tubes containing TYG medium, 9 produced C2 toxin which required trypsin treatment before toxicity could be demonstrated (Table 4 ). The C2 toxin of strains 2429, A022, and UV84 could be detected only when cultured in cellophane tubes containing TYG medium. Trypsinization was not needed to demonstrate toxicity; however, toxicity was increased by trypsin treatment.
Production of C2 toxin by type D strains. Type D strains "cured" of their prophages and dominant toxic component were used (Table 5) . Only strain AOA113 produced the C2 component, and trypsin treatment was required to obtain toxicity. The C2 toxin produced was neutralized by the C2 antisera.
Effect of bacteriophage or C, toxin, or both, on the toxicity of C2 toxin produced by types C and D strains. Strain A028 (which has been cured of prophages CE, and CE,) and the parent strain 468C (which carries both CE, and CE0 prophages) were cultured in SFEM media containing 0.3% glucose and 0.5% (NH4)2SO4 and in TYG media at 33 C.
When samples of the culture were assayed daily, the C, toxin was present in strain 468C after 1 day of incubation (200 LD5,/ml). The C2 toxin was not detectable in either 468C or A028 until after 2 days of incubation. Maximum levels of the C2 toxin (350 LD,0/ml) were reached in both cultures after 3 days of incubation. The C2 toxin produced by both cultures was toxic only after trypsin treatment.
When the Stockholm strain was grown in SFEM or TYG medium for 3 days, both the C1 and C2 toxins were produced; the C2 titer was 4 LD,0/ml without trypsin treatment. In contrast, the C2 toxin in a 3-and 8-day-old culture of A050 (which is "cured" of both prophages CE, and CE0 and does not produce C1 toxin) required trypsin treatment before its lethality could be demonstrated. Culture A050, infected with bacteriophage CE, which does not induce the production of the C1 toxin, develops C2 toxin whose toxicity is not evident without treatment with trypsin. The presence of bacteriophage CE0 or the C1 toxin, or both, therefore appears to have some effect on the presence of small quantities of active C2 toxin in the culture supernatant fluid of the Stockholm strain.
None of the bacteriophages of six type C strains and one type D strain appears to govern the production of the C2 toxin. DISCUSSION The exposure of culture supernatant fluids of nonproteolytic types B, E, and F (3, 4, 7-9, 12, 13, 20) and of young cultures of proteolytic types A, B, and F (1, 11, 13) to trypsin results in increased toxicity. No significant increases in toxicity, however, have been reported by treating the supernatant fluid of types C and D cultures with trypsin (13, 21) . The activation effect of trypsin on C2 toxin probably was not recognized previously because cultures producing this toxin develop a higher toxicity level of either Cl or D toxin. Unless the Cl and D toxins are specifically neutralized, increases of C2 toxicity by trypsin would be masked and undetected. The toxicity of the Cl and D components are not increased by trypsin treatment. In addition, when types C and D cultures discontinue to produce their dominant C1 and D components, the C2 toxin is not detectable unless the culture supernatant fluids are treated with trypsin. With C. botulinum types A, B, E, and F, lethal levels of the toxin are usually present in the culture supernatant fluid without trypsin or similar treatments, and the toxicity is increased by trypsin. In contrast, the data from this current study show that of the 21 type C cultures that produce both the C, and C2 toxins, 14 cultures required trypsin treatment before the C2 toxin could be detected. The C2 toxin produced by "nontoxic" cultures (that no longer produce the dominant toxins C, and D) also required trypsin treatment for toxicity. If these cultures were cultured in cellophane tubes immersed in TYG medium, then the C2 toxin could be detected without trypsin.
The serological relationship of C. botulinum types Ca, CQ, and D is somewhat unclear. The data of Pfenninger (19) show that the antitoxin prepared against type Ca neutralized the toxins of types C,,, and C,, whereas the serum against type C, neutralized only the C0 toxin. The studies of Bulatova et al. (2) , however, show that C, and C0 antisera cross-neutralize with C, and C0 toxins and that type D produces types C, and C, toxins. Jansen's (16) (iii) The medium influences the production of the C2 toxin. In our studies, high concentrations of glucose markedly inhibited the pro-duction of the C2 toxin. Jansen (16) reported that the C2 toxin was not produced in horse meat sausage, but it was produced in liquid medium with the cellophane tube procedure.
From a practical view, it is essential to recognize that type C and D cultures produce the trypsin-activable toxin C2 so that antiserum prepared against these toxins will include the C2 component. Several of the types C and D antisera discussed in this report do not contain the C2 factor.
When the Stockholm and 468C strains of type C and the 1873 strain of type D are "cured" of their prophages, they concomitantly discontinue the production of their dominant toxins. These "cured" isolates then become indistinguishable because they continue to produce only the C2 toxin.
It is interesting that, of the two toxins produced by the same organism, one toxin (C2) requires trypsin treatment for toxicity whereas the other toxins (Cl or D) do not. Lamanna and Sakaguchi (17) state that a trypsin-treated preparation of an impure toxin can show increases in toxicity when treated with trypsin because of (i) intramolecular changes resulting in generation of new or increased toxicity, (ii) separation of a toxin from associated nontoxic components in an aggregate of complex, or (iii) conversion of nontoxic protein to a toxic state. Ultimately, purified preparations of the C2 toxin will therefore have to be used to determine the mechanism involved in the increases in toxicity of the C2 toxin during treatment with trypsin.
